Navigation Links
CutisPharma Launches New Prescription Mouthwash Kit Adding to Product Line
Date:9/22/2009

WOBURN, Mass., Sept. 22 /PRNewswire/ -- CutisPharma, Inc. announced the introduction of FIRST(R) - BXN Mouthwash. It is the second in the FIRST(R) Mouthwash Compounding Kit product line, which already includes FIRST(R) - Mouthwash BLM. The active ingredients in FIRST(R) - BXN Mouthwash are comparable to those found in the most routinely prepared formulation of Magic Mouthwash containing Benadryl(R), Xylocaine 2% viscous(R), and nystatin. The kits are made for one patient and include pre-weighed diphenhydramine hydrochloride, lidocaine hydrochloride, and nystatin powder, and a pre-measured suspension. With FIRST(R) - BXN Mouthwash, the pharmacist needs only to add the powders to the liquid suspension, shake, and then dispense to the patient.

"By launching FIRST(R) - BXN, physicians now have two of the more commonly prescribed magic mouthwash prescriptions available in a kit," said Dr. Indu Muni, founder, chairman, and CEO of CutisPharma, Inc. "The Company anticipates launching two additional Mouthwash products, FIRST(R) - Mary's Mouthwash, and FIRST(R) - Duke's Mouthwash, in the near future, thus completing the Mouthwash product line."

FIRST(R) products save dispensing time, and can be compounded by the pharmacist while the patient waits, increasing customer satisfaction. Using FIRST(R) Mouthwash kits, the pharmacist can compound a prescription faster than those prepared in the conventional way. A single NDC number assigned for the entire Kit facilitates the third party reimbursement process, and reduces audit- related adjustments.

CutisPharma now has ten proprietary prescription compounding kits on the market: five progesterone suppository compounding kits, two testosterone kits, one hydrocortisone kit, and two Magic Mouthwash kits. Several more compounding kits are in the planning stages. FIRST((R)) Unit-of-Use Prescription Compounding Kits comply with United States Pharmacopeia (USP) Chapter <795>.

The FDA estimates that each year in the United States approximately 30 million retail and hospital outpatient prescriptions are prepared through "compounding," a means by which a pharmacist prepares a customized medication according to a doctor's prescription to meet an individual patient's medical need. About 1% of all prescriptions are compounded; and the U.S. market alone for compounding, at the consumer level, represents an estimated $1 billion annually.

About CutisPharma

CutisPharma, Inc. based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST(R) Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Two U.S. patents have been issued to the Company with several additional patents pending.

For more information please visit our website at www.cutispharma.com


'/>"/>
SOURCE CutisPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RESOLVE: The National Infertility Association Announces Partnership With CutisPharma
2. CutisPharma Announces Issuance of a Patent for Suppository Compounding
3. CutisPharma Announces Strategic Collaboration with Rite Aid Corporation
4. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
5. MEDISON Launches New Dedicated OB/GYN 3D/4D Ultrasound System, ACCUVIX V20 Prestige
6. Webmedx Launches New Data-Mining Solution for Medical Transcription and Speech-Generated Documents
7. World Health Organization Launches New Attack on Lung Cancer
8. Thomson Reuters Launches Thomson Pharma Partnering Forecast
9. https://happier.com/form.htmhappier.com Launches a Personal Trainer for Your Happiness
10. American Lung Association Launches Retro Marketing Initiative to Support 2009 Christmas Seals(R) Campaign
11. LYSOL(R) Launches Healthier Habits Rewards Program at Schools Nationwide to Help Protect Families from Germs, Such as H1N1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... How big is ... facilities, and who are the most active developers? , In the first ... Real Estate Insights (HREI) found that outpatient medical real estate development projects totaling ...
(Date:3/29/2017)... ... 29, 2017 , ... The assembly of synthetic DNA has ... repetitive steps and often scientists require many different versions of DNA. Therefore, this ... in a lower error rate and cost saving for reagents and consumables. , ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... The Wharton ... WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to establish ... admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified Penn ...
(Date:3/28/2017)... , ... March 28, 2017 , ... For many women, getting birth control isn’t as ... , meaning they either don’t have access to a health care facility or a pharmacy ... remote regions of the United States or for many who are faced with health or ...
(Date:3/28/2017)... ... 29, 2017 , ... The Thyroid Secret is a specialized ... The program was recently launched on March 1, and Dr. Wentz discussed varied ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
(Date:3/29/2017)... , March 29, 2017  Maxor National Pharmacy ... announced that it has named Leah Bailey ... all divisions of the company. With more ... the previous 8 years focused on health care, Bailey ... her tenure at Prime, Bailey advised the PBM, Specialty, ...
(Date:3/29/2017)... Varian Medical Systems (NYSE: VAR ) ... quarter of fiscal year 2017 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ... call and replay: ...
Breaking Medicine Technology: